Zebra Capital Management LLC Cytosorbents Corp Transaction History
Zebra Capital Management LLC
- $20 Million
- Q1 2023
Shares
2 transactions
Others Institutions Holding CTSO
# of Institutions
57Shares Held
16.9MCall Options Held
10.1KPut Options Held
500-
Avenir Corp Washington, DC2.97MShares$3.03 Million0.21% of portfolio
-
Skylands Capital, LLC2.84MShares$2.9 Million0.3% of portfolio
-
Granahan Investment Management, LLC Waltham, MA2.66MShares$2.72 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.99 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.54MShares$1.57 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $44.4M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...